4 days ago
Morgan Stanley Keeps Their Hold Rating on SanBio Co (SNBIF)
In a report released on May 29, Shinichiro Muraoka from Morgan Stanley maintained a Hold rating on SanBio Co (SNBIF – Research Report), with a price target of Yen1,400.00.
Confident Investing Starts Here:
Muraoka covers the Healthcare sector, focusing on stocks such as SanBio Co, Astellas Pharma, and Daiichi Sankyo Company. According to TipRanks, Muraoka has an average return of -3.9% and a 33.33% success rate on recommended stocks.
The word on The Street in general, suggests a Moderate Sell analyst consensus rating for SanBio Co with a $5.83 average price target.
Based on SanBio Co's latest earnings release for the quarter ending January 31, the company reported a quarterly GAAP net loss of $730.52 million. In comparison, last year the company had a GAAP net loss of $761.28 million
